Synonyms: compound 2 [PMID: 23124563] | KRP-203 | KRP203
Compound class:
Synthetic organic
Comment: Mocravimod (KRP203) is a sphingosine 1-phosphate receptor type 1 (S1P1R) agonist with immunomodulatory potential [6]. Structurally mocravimod is a highly modified analogue of the approved multiple sclerosis drug fingolimod. Like fingolimod it is a prodrug that is phosphorylated in vivo by sphingosine kinase 2 (SPHK2), with mocravimod-phosphate (+KRP203-phosphate) being the active entity.
|
|
Immunopharmacology Comments |
S1P receptor agonists modulate lymphocyte recirculation and lead to immunosuppression. Selective S1P1R agonists are being developed and investigated for immunomodulatory/immunosuppresant potential, with reduced potential to induce the cardiac adverse effect bradycardia [1,4]. |